Skip to main content

Childhood Mortality clinical trials at UCSF
1 in progress, 0 open to new patients

  • Mortality Reduction After Oral Azithromycin Contingency: Mortality Study

    Sorry, not currently recruiting here

    In the event that MORDOR (NCT02047981) established the efficacy of oral azithromycin in preventing mortality in 1-59 month children, the contingency study was to treat both arms in Niger with oral azithromycin (unmasked) for two more years in Niger only.

    San Francisco, California and other locations